Skip to main content
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1976 May;60(5):312–323. doi: 10.1136/bjo.60.5.312

Pathology of practolol-induced ocular toxicity.

A H Rahi, C M Chapman, A Garner, P Wright
PMCID: PMC1042724  PMID: 952801

Abstract

The ocular side-effects of prolonged practolol administration concern the cornea and conjunctiva and are related to deficient tear secretion and the formation of an autoantibody which has an affinity for the intercellular zones of squanmous epithelium. Histopathological study of six cases, including a review of the necropsy findings in two, showed destruction of lacrimal gland tissue, epidermalization of the conjunctival epithelium, with epitheliolysis and stromal ulceration of the cornea leading to perforation in two patients. Immunoperoxidase studies showed fixation of specific antibody in the corneal and conjunctival epithelium but, in the one case in which the tissue could be adequately studied, complement fixation could not be demonstrated. Possibly, therefore, the immune response in patients with practolol-induced ocular damage is secondary to the epithelial disturbance rather than its cause.

Full text

PDF
312

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown P., Baddeley H., Read A. E., Davies J. D., McGarry J. Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol). Lancet. 1974 Dec 21;2(7895):1477–1481. doi: 10.1016/s0140-6736(74)90218-9. [DOI] [PubMed] [Google Scholar]
  2. Dohlman C. H. New concepts in ocular xerosis. Trans Ophthalmol Soc U K. 1971;91:105–118. [PubMed] [Google Scholar]
  3. Editorial: Treatment of senile macular degeneration. Br Med J. 1975 Apr 5;2(5961):6–6. doi: 10.1136/bmj.2.5961.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Felix R. H., Ive F. A., Dahl M. G. Cutaneous and ocular reactions to practolol. Br Med J. 1974 Nov 9;4(5940):321–324. doi: 10.1136/bmj.4.5940.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lemp M. A., Dohlman C. H., Kuwabara T., Holly F. J., Carroll J. M. Dry eye secondary to mucus deficiency. Trans Am Acad Ophthalmol Otolaryngol. 1971 Nov-Dec;75(6):1223–1227. [PubMed] [Google Scholar]
  6. Meyboom R. H. Letter: Practolol and sclerosing peritonitis. Lancet. 1975 Feb 8;1(7902):334–335. doi: 10.1016/s0140-6736(75)91242-8. [DOI] [PubMed] [Google Scholar]
  7. Raftery E. B., Denman A. M. Systemic lupus erythematosus syndrome induced by practolol. Br Med J. 1973 May 26;2(5864):452–455. doi: 10.1136/bmj.2.5864.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Slansky H. H., Dohlman C. H. Collagenase and the cornea. Surv Ophthalmol. 1970 Mar;14(5):402–415. [PubMed] [Google Scholar]
  9. Taylor C. R., Burns J. The demonstration of plasma cells and other immunoglobulin-containing cells in formalin-fixed, paraffin-embedded tissues using peroxidase-labelled antibody. J Clin Pathol. 1974 Jan;27(1):14–20. doi: 10.1136/jcp.27.1.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Tripathi R. C., Bron A. J. Cystic disorders of the corneal epithelium. II. Pathogenesis. Br J Ophthalmol. 1973 Jun;57(6):376–390. doi: 10.1136/bjo.57.6.376. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES